208 related articles for article (PubMed ID: 35731524)
1. Association of Changes in Antithrombin Activity Over Time With Responsiveness to Enoxaparin Prophylaxis and Risk of Trauma-Related Venous Thromboembolism.
Vincent LE; Talanker MM; Butler DD; Zhang X; Podbielski JM; Wang YW; Chen-Goodspeed A; Hernandez Gonzalez SL; Fox EE; Cotton BA; Wade CE; Cardenas JC
JAMA Surg; 2022 Aug; 157(8):713-721. PubMed ID: 35731524
[TBL] [Abstract][Full Text] [Related]
2. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
[TBL] [Abstract][Full Text] [Related]
3. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
[TBL] [Abstract][Full Text] [Related]
4. Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial.
Connelly CR; Van PY; Hart KD; Louis SG; Fair KA; Erickson AS; Rick EA; Simeon EC; Bulger EM; Arbabi S; Holcomb JB; Moore LJ; Schreiber MA
JAMA Surg; 2016 Oct; 151(10):e162069. PubMed ID: 27487253
[TBL] [Abstract][Full Text] [Related]
5. Supplementation with antithrombin III ex vivo optimizes enoxaparin responses in critically injured patients.
Cardenas JC; Wang YW; Karri JV; Vincent S; Cap AP; Cotton BA; Wade CE
Thromb Res; 2020 Mar; 187():131-138. PubMed ID: 31986476
[TBL] [Abstract][Full Text] [Related]
6. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care.
Rakhra S; Martin EL; Fitzgerald M; Udy A
Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829
[TBL] [Abstract][Full Text] [Related]
7. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
[TBL] [Abstract][Full Text] [Related]
8. Relation of antifactor-Xa peak levels and venous thromboembolism after trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Martin AG; Lineen EB; Namias N; Schulman CI; Proctor KG
J Trauma Acute Care Surg; 2017 Dec; 83(6):1102-1107. PubMed ID: 29190255
[TBL] [Abstract][Full Text] [Related]
9. Bioactivity of enoxaparin in critically ill patients with normal renal function.
Gouya G; Palkovits S; Kapiotis S; Madl C; Locker G; Stella A; Wolzt M; Heinz G
Br J Clin Pharmacol; 2012 Nov; 74(5):806-14. PubMed ID: 23227470
[TBL] [Abstract][Full Text] [Related]
10. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
[TBL] [Abstract][Full Text] [Related]
11. Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
Rahbar E; Cotton BA; Wade CE; Cardenas JC
Thromb Res; 2021 Aug; 204():9-12. PubMed ID: 34091120
[TBL] [Abstract][Full Text] [Related]
12. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
14. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T
Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688
[TBL] [Abstract][Full Text] [Related]
15. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
Walker CK; Sandmann EA; Horyna TJ; Gales MA
Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
[TBL] [Abstract][Full Text] [Related]
16. Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial.
Droege ME; Droege CA; Philpott CD; Webb ML; Ernst NE; Athota K; Wakefield D; Dowd JR; Gomaa D; Robinson BHR; Hanseman D; Elterman J; Mueller EW
J Thromb Thrombolysis; 2021 Nov; 52(4):1117-1128. PubMed ID: 33978907
[TBL] [Abstract][Full Text] [Related]
17. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis.
Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA
J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842
[TBL] [Abstract][Full Text] [Related]
18. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients.
Kramme K; Sarraf P; Munene G
J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692
[TBL] [Abstract][Full Text] [Related]
20. Impact of Increased Enoxaparin Dosing on Anti-Xa Levels for Venous Thromboembolism Prophylaxis in Trauma Patients.
Bellfi LT; Zimmerman SA; Boudreau R; Mosier W; Smith A; Rueb N; Hunt JP; Stuke L; Greiffenstein P; Schoen J; Marr A
Am Surg; 2022 Sep; 88(9):2158-2162. PubMed ID: 35839754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
